Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05359848 · ClinicalTrials.gov registry record · NA
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
A NA study of Medical Oncology and Integrative Oncology, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05359848: Recruiting NA study of Medical Oncology and Integrative Oncology, sponsored by State University of New York at Buffalo.
NCT05359848 is a NA study of Medical Oncology and Integrative Oncology that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 30 participants, below the 253-participant average among 3 other Medical Oncology trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05359848, a NA study of Medical Oncology and Integrative Oncology, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard treatment of cancer.
Primary Outcome
enrollment rate
Conditions Studied
Interventions
- OTHER Diet
Study Locations (2)
New York
- University at Buffalo / Great Lakes Cancer Care - Buffalo
- University at Buffalo / Great Lakes Cancer Care - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT05359848 shows while recruiting
NCT05359848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 253-participant average among 3 other Medical Oncology trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Medical Oncology appearing as the primary indexed condition, and to 1 intervention - of which Diet is the first listed.
NCT05359848 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05359848 about?
NCT05359848 is a clinical study titled "A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy". Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard ...
What is the current status of trial NCT05359848?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-04-15. Estimated completion is 2027-06-01.
What conditions does trial NCT05359848 study?
This clinical trial studies the following conditions: Medical Oncology, Integrative Oncology, Medical Nutrition Therapy.
What interventions are being tested in trial NCT05359848?
The interventions under investigation include: Diet (OTHER).
Who is sponsoring clinical trial NCT05359848?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05359848 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medical Oncology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
RECRUITING · NA
-
Ezra Faster Scan Study
COMPLETED
-
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI